AUG 11, 2026 · PHASE 3 TRIAL
Testing the Addition of an Antibody to Standard Chemoradiation Followed by the Antibody for One Year to Standard Chemoradiation Followed by One Year of the Antibody in Patients With Unresectable Stage III Non-Small Cell Lung Cancer
ClinicalTrials.gov
This is a Phase 3 trial registration with no reported results; the study is active but not yet recruiting and outcome data are not posted in this registry record.
Reported
PhasePHASE 3
Planned enrollment660
Primary outcome measureOverall survival (OS), from randomization t…